BSX insider transaction filings
BOSTON SCIENTIFIC CORP — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-12. Screen BSX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Woodworth Emily — SVP, Global Controller and CAO | Code (I): 2,930 @ $51.19 | EDGAR |
| 2026-08-11 | 4 | Monson Jonathan — EVP and CFO | Code (I): 9,908 @ $50.46 | EDGAR |
| 2026-08-07 | 4 | Habiger David C — Director | Purchase (P): 2,100 @ $47.59 | EDGAR |
| 2026-08-05 | 4 | Mahoney Michael F — Chairman, President & CEO, Director | Purchase (P): 186,240 @ $48.33 · Code (I): 22,119 @ $48.43 | EDGAR |
| 2026-08-05 | 4 | Habiger David C — Director | Purchase (P): 1,042 @ $48.07 · Purchase (P): 140 @ $48.59 | EDGAR |
| 2026-08-03 | 4 | Fitzgerald Joseph Michael — EVP & Group Pres, Cardiology | Code (I): 64,198 @ $46.73 | EDGAR |
| 2026-08-03 | 4 | LUDWIG EDWARD J — Director | Purchase (P): 5,000 @ $45.48 | EDGAR |
| 2026-07-02 | 4 | Monson Jonathan — EVP and CFO | Option exercise (M): 2,087 @ $0 · Tax withholding (F): 1,010 @ $43.06 · Option exercise (M): 2,087 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Mahoney Michael F — Chairman, President & CEO, Director | Gift (G): 386,755 @ $0 | EDGAR |
| 2026-05-21 | 4 | Pegus Cheryl — Director | Purchase (P): 1,770 @ $56.49 | EDGAR |
| 2026-05-21 | 4 | Habiger David C — Director | Purchase (P): 2,200 @ $56.95 · Purchase (P): 2,250 @ $55.92 | EDGAR |
| 2026-05-21 | 4 | LUDWIG EDWARD J — Director | Purchase (P): 3,580 @ $56.68 | EDGAR |
| 2026-05-11 | 4 | Weber Christophe Pierre — Director | Grant/award (A): 1,767 @ $0 · Grant/award (A): 1,140 @ $0 · Grant/award (A): 2,660 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Morano Susan E — Director | Grant/award (A): 3,800 @ $0 · Grant/award (A): 1,281 @ $0 | EDGAR |
| 2026-05-11 | 4 | Mega Jessica L — Director | Grant/award (A): 3,800 @ $0 | EDGAR |
| 2026-05-11 | 4 | Pegus Cheryl — Director | Grant/award (A): 3,800 (derivative) @ $0 · Grant/award (A): 1,281 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Zane Ellen M — Director | Grant/award (A): 3,800 @ $0 | EDGAR |
| 2026-05-11 | 4 | Habiger David C — Director | Grant/award (A): 3,800 @ $0 | EDGAR |
| 2026-05-11 | 4 | Smith Cathy R — Director | Grant/award (A): 3,800 (derivative) @ $0 · Grant/award (A): 2,209 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | WICHMANN DAVID S — Director | Grant/award (A): 3,800 @ $0 | EDGAR |
| 2026-05-11 | 4 | LUDWIG EDWARD J — Director | Grant/award (A): 3,800 @ $0 | EDGAR |
| 2026-05-04 | 4 | O'Connor Padraig Andrew — EVP, Global Operations | Option exercise (M): 1,802 @ $0 · Tax withholding (F): 872 @ $56.50 · Option exercise (M): 1,802 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Butcher Arthur C — EVP& Grp Pres, MedSurg & APAC | Option exercise (M): 2,102 @ $0 · Tax withholding (F): 1,007 @ $56.50 · Option exercise (M): 2,102 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Weber Christophe Pierre — Director | Grant/award (A): 556 @ $0 · Grant/award (A): 323 @ $0 | EDGAR |
| 2026-03-04 | 4 | Morano Susan E — Director | Grant/award (A): 24 @ $0 | EDGAR |
| 2026-03-04 | 4 | Pegus Cheryl — Director | Grant/award (A): 24 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Smith Cathy R — Director | Grant/award (A): 556 (derivative) @ $0 · Grant/award (A): 323 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Woodworth Emily — SVP, Global Controller and CAO | Option exercise (M): 838 @ $0 · Tax withholding (F): 372 @ $76.85 · Option exercise (M): 838 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Butcher Arthur C — EVP& Grp Pres, MedSurg & APAC | Code (I): 6,851 @ $75.76 | EDGAR |
| 2026-02-18 | 4 | O'Connor Padraig Andrew — EVP, Global Operations | Option exercise (M): 500 @ $0 · Tax withholding (F): 199 @ $74.73 · Option exercise (M): 1,190 @ $0 · Tax withholding (F): 449 @ $74.73 · Option exercise (M): 905 @ $0 · Tax withholding (F): 339 @ $74.73 · +3 more | EDGAR |
| 2026-02-18 | 4 | O'Sullivan Miriam — SVP, Chief HR Officer | Option exercise (M): 588 @ $0 · Tax withholding (F): 200 @ $74.73 · Option exercise (M): 1,124 @ $0 · Tax withholding (F): 329 @ $74.73 · Option exercise (M): 990 @ $0 · Tax withholding (F): 291 @ $74.73 · +3 more | EDGAR |
| 2026-02-18 | 4 | Woodworth Emily — SVP, Global Controller and CAO | Option exercise (M): 1,413 @ $0 · Tax withholding (F): 690 @ $74.73 · Option exercise (M): 661 @ $0 · Tax withholding (F): 296 @ $74.73 · Option exercise (M): 637 @ $0 · Tax withholding (F): 283 @ $74.73 · +3 more | EDGAR |
| 2026-02-18 | 4 | Brown Vance R — EVP, GC and Corp. Secretary | Grant/award (A): 14,804 @ $0 · Grant/award (A): 14,804 @ $0 · Option exercise (M): 1,118 @ $0 · Tax withholding (F): 12,792 @ $74.73 · Option exercise (M): 1,851 @ $0 · Tax withholding (F): 895 @ $74.73 · +5 more | EDGAR |
| 2026-02-18 | 4 | Monson Jonathan — EVP and CFO | Option exercise (M): 1,766 @ $0 · Tax withholding (F): 788 @ $74.73 · Option exercise (M): 1,058 @ $0 · Tax withholding (F): 470 @ $74.73 · Option exercise (M): 990 @ $0 · Tax withholding (F): 440 @ $74.73 · +3 more | EDGAR |
| 2026-02-18 | 4 | Butcher Arthur C — EVP& Grp Pres, MedSurg & APAC | Grant/award (A): 25,380 @ $0 · Grant/award (A): 25,380 @ $0 · Option exercise (M): 2,237 @ $0 · Tax withholding (F): 25,150 @ $74.73 · Option exercise (M): 3,173 @ $0 · Tax withholding (F): 1,535 @ $74.73 · +5 more | EDGAR |
| 2026-02-18 | 4 | Mahoney Michael F — Chairman, President & CEO, Director | Grant/award (A): 132,190 @ $0 · Grant/award (A): 132,190 @ $0 · Option exercise (M): 8,832 @ $0 · Tax withholding (F): 132,099 @ $74.73 · Option exercise (M): 16,524 @ $0 · Tax withholding (F): 7,990 @ $74.73 · +5 more | EDGAR |
| 2026-02-18 | 4 | Fitzgerald Joseph Michael — EVP & Group Pres, Cardiology | Grant/award (A): 34,898 @ $0 · Grant/award (A): 34,898 @ $0 · Option exercise (M): 2,797 @ $0 · Tax withholding (F): 33,104 @ $74.73 · Option exercise (M): 4,362 @ $0 · Tax withholding (F): 1,990 @ $74.73 · +5 more | EDGAR |
| 2026-02-17 | 4 | O'Connor Padraig Andrew — EVP, Global Operations | Option exercise (M): 1,058 @ $0 · Tax withholding (F): 457 @ $74.12 · Option exercise (M): 1,058 (derivative) @ $0 · Grant/award (A): 5,059 (derivative) @ $0 · Grant/award (A): 11,939 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | O'Sullivan Miriam — SVP, Chief HR Officer | Option exercise (M): 961 @ $0 · Tax withholding (F): 338 @ $74.12 · Option exercise (M): 961 (derivative) @ $0 · Grant/award (A): 4,722 (derivative) @ $0 · Grant/award (A): 11,143 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Woodworth Emily — SVP, Global Controller and CAO | Option exercise (M): 481 @ $0 · Tax withholding (F): 242 @ $74.12 · Option exercise (M): 481 (derivative) @ $0 · Grant/award (A): 6,071 (derivative) @ $0 · Grant/award (A): 5,584 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Brown Vance R — EVP, GC and Corp. Secretary | Option exercise (M): 1,442 @ $0 · Tax withholding (F): 488 @ $74.12 · Option exercise (M): 1,442 (derivative) @ $0 · Grant/award (A): 7,420 (derivative) @ $0 · Grant/award (A): 17,510 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Monson Jonathan — EVP and CFO | Option exercise (M): 1,154 @ $0 · Tax withholding (F): 573 @ $74.12 · Option exercise (M): 1,154 (derivative) @ $0 · Grant/award (A): 11,805 (derivative) @ $0 · Grant/award (A): 27,857 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Butcher Arthur C — EVP& Grp Pres, MedSurg & APAC | Option exercise (M): 2,692 @ $0 · Tax withholding (F): 1,302 @ $74.12 · Option exercise (M): 2,692 (derivative) @ $0 · Grant/award (A): 15,178 (derivative) @ $0 · Grant/award (A): 35,817 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Mahoney Michael F — Chairman, President & CEO, Director | Option exercise (M): 13,704 @ $0 · Tax withholding (F): 6,626 @ $74.12 · Option exercise (M): 13,704 (derivative) @ $0 · Grant/award (A): 55,652 (derivative) @ $0 · Grant/award (A): 131,329 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Fitzgerald Joseph Michael — EVP & Group Pres, Cardiology | Option exercise (M): 3,462 @ $0 · Tax withholding (F): 1,612 @ $74.12 · Option exercise (M): 3,462 (derivative) @ $0 · Grant/award (A): 18,550 (derivative) @ $0 · Grant/award (A): 43,776 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Mahoney Michael F — Chairman, President & CEO, Director | Option exercise (M): 49,407 @ $24.55 · Option exercise (M): 46,347 @ $27.09 · Sale (S): 1,200 @ $94.06 · Sale (S): 159,701 @ $93.49 · Option exercise (M): 46,347 (derivative) @ $0 · Option exercise (M): 49,407 (derivative) @ $0 | EDGAR |
| 2025-12-02 | 4 | Butcher Arthur C — EVP& Grp Pres, MedSurg & APAC | Option exercise (M): 6,952 @ $27.09 · Option exercise (M): 6,175 @ $24.55 · Option exercise (M): 3,177 @ $22.71 · Option exercise (M): 1,009 @ $17.26 · Sale (S): 17,313 @ $101.55 · Option exercise (M): 6,952 (derivative) @ $0 · +3 more | EDGAR |
| 2025-12-01 | 4 | O'Sullivan Miriam — SVP, Chief HR Officer | Gift (G): 260 @ $0 | EDGAR |
| 2025-11-14 | 4 | Fitzgerald Joseph Michael — EVP & Group Pres, Cardiology | Gift (G): 690 @ $0 · Gift (G): 9,610 @ $0 | EDGAR |
| 2025-11-06 | 4 | Zane Ellen M — Director | Sale (S): 12,891 @ $98.28 | EDGAR |
Recent 8-K events — BOSTON SCIENTIFIC CORP
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-27 | 8-K | ? | EDGAR |
| 2026-05-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BSX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →